Studsvik

Studsvik

Sälj aktien Köp aktien Handla aktien direkt på nordnet

« Tillbaka

Studsvik - Gearing up for the new-build era

13 juli 2026

  • Q2 report out on 17 July
  • Q2e sales of SEK 228m, flat y-o-y; EBIT adj. SEK 15m (16m)
  • Trading at '26e/'27e/'28e EV/EBIT of 27x/22x/20x

Q2 expectations

We expect Q2 sales to be flat y-o-y at SEK 229m, with adj. EBIT of SEK 15m (16m) for an adj. margin of 6.8% (6.9%). For FM&WM, we expect continued good momentum and estimate sales of SEK 109m (107m) for an adj. margin of 16.4% (16.2%). Scandpower remains volatile due to the quarterly nature of software licence sales; we estimate sales of SEK 37m (36m) for an adj. EBIT margin of 7% (6.5%). For Decommissioning, persistent competitor price pressure continues to weigh on the segment's near-term profitability in the segment. However, we think margins will continue to stabilise following Q1 structural improvements such as improved capacity utilisation and cost efficiencies. We estimate a Q2 EBIT margin of 4.6% (4.9%).

Estimate changes

We lower '26e EBIT by 3% and leave '27e-'28e broadly unchanged ahead of the Q1 report.

New-build optionality starts to take shape

The SMR optionality acquired with Kärnfull Next, completed in May, is becoming a reality: Studsvik has applied for government approval of up to 1,400 MW of new nuclear power at its own site in Nyköping, and for state support covering both this and a second project in Valdemarsvik (~1,200-1,600 MW), with a county facility plan due by end-2026. Other parts of the business are also progressing: in June, the NRC approved an extension of Scandpower's CMS5 software for use with higher enrichment, higher burnup and light-water SMR designs. As well, a fuel-technology collaboration with Lightbridge was announced in May. The stock is trading at '26e-'28e EV/EBIT of 27x-20x on our estimates.

Senaste artiklar från alla bolag

Datum Titel Bolag Typ
2026-07-15 Infrea - Strong quarter but pegged to Netel Infrea Analys
2026-07-15 Coor - Solid earnings despite softer sales Coor Analys
2026-07-15 Svedbergs Group - Nordics and one-offs weigh Svedbergs G.. Analys
2026-07-14 Nexam Chemical - Solid Q2, profitability within r... Nexam Chemical Analys
2026-07-14 Nexam Chemical - Record sales and first positive ... Nexam Chemical Analys
2026-07-14 Eastnine - Warsaw to become the largest market Eastnine Analys
2026-07-13 Ascelia Pharma - CRL update Ascelia Pharma Analys
2026-07-13 Medicover - Steady as she goes Medicover Analys
2026-07-13 Arctic Paper - Pulp beats paper Arctic Paper Analys
2026-07-13 Studsvik - Gearing up for the new-build era Studsvik Analys
2026-07-10 StrongPoint - The American dream StrongPoint Analys
2026-07-10 Careium - The pressure valve starting to open Careium Analys
2026-07-10 StrongPoint - Solid Q2 performance StrongPoint Analys
2026-07-10 Careium - Growth's comeback tour continues Careium Analys
2026-07-09 Infrea - Road tripping with Netel Infrea Analys
2026-07-08 Alligo - Softer growth, but margin recovery conti... Alligo Analys
2026-07-08 Qliro - Key earnings drivers intact Qliro Analys
2026-07-07 Nexam Chemical - We expect a firmer sequential qu... Nexam Chemical Analys
2026-07-07 Eastnine - Adding in Warsaw Eastnine Analys
2026-07-06 Ovzon - No Q2 fireworks, but plenty of fuel Ovzon Analys